123 related articles for article (PubMed ID: 30275209)
21. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
[TBL] [Abstract][Full Text] [Related]
22. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
[TBL] [Abstract][Full Text] [Related]
23. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
[TBL] [Abstract][Full Text] [Related]
24. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
25. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
26. High-dose rate intraluminal brachytherapy: An effective palliation for cholangiocarcinoma causing bile duct obstruction.
Nguyen NA; Timotin E; Hunter R; Sur RK
Surg Oncol; 2018 Dec; 27(4):625-629. PubMed ID: 30449482
[No Abstract] [Full Text] [Related]
27. Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients with unresectable colorectal liver metastases compared with mono-CT-HDRBT.
Friedrich S; Busch F; Jonczyk M; Wieners G; Böning G; Lüdemann WM; Meddeb A; Collettini F; Gebauer B
J Contemp Brachytherapy; 2023 Feb; 15(1):15-26. PubMed ID: 36970444
[TBL] [Abstract][Full Text] [Related]
28. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy.
Collettini F; Schippers AC; Schnapauff D; Denecke T; Hamm B; Riess H; Wust P; Gebauer B
Br J Radiol; 2013 Jul; 86(1027):20130088. PubMed ID: 23659925
[TBL] [Abstract][Full Text] [Related]
30. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation.
Mosconi C; Cucchetti A; Bruno A; Cappelli A; Bargellini I; De Benedittis C; Lorenzoni G; Gramenzi A; Tarantino FP; Parini L; Pettinato V; Modestino F; Peta G; Cioni R; Golfieri R
Eur Radiol; 2020 Aug; 30(8):4534-4544. PubMed ID: 32227266
[TBL] [Abstract][Full Text] [Related]
31. Role of intraluminal brachytherapy as a palliative treatment modality in unresectable cholangiocarcinomas.
Chigurupalli K; Vashistha A
J Cancer Res Ther; 2021; 17(1):10-12. PubMed ID: 33723125
[TBL] [Abstract][Full Text] [Related]
32. Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma.
Onal C; Topuk S; Yapar AF; Yavuz M; Topkan E; Yavuz A
Onkologie; 2013; 36(9):484-90. PubMed ID: 24051924
[TBL] [Abstract][Full Text] [Related]
33. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
[TBL] [Abstract][Full Text] [Related]
34. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
35. A quality assurance device for measuring afterloader performance and transit dose for nasobiliary high-dose-rate brachytherapy.
Deufel CL; Mullins JP; Zakhary MJ
Brachytherapy; 2018; 17(4):726-731. PubMed ID: 29779953
[TBL] [Abstract][Full Text] [Related]
36. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
[TBL] [Abstract][Full Text] [Related]
37. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
38. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
39. Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Steffen IG; Wust P; Rühl R; Grieser C; Schnapauff D; Lüdemann L; Grabik W; Ricke J; Amthauer H; Hamm B; Hänninen EL; Denecke T
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1178-85. PubMed ID: 20056343
[TBL] [Abstract][Full Text] [Related]
40. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
